Proprietary technology with a high probability of generating novel, clinical products.
Provides individual immune profiles or signatures that can inform diagnosis and therapies.
CancerProbe’s novel technology uses the lymph nodes, which drain a cancer, for harvesting the anti-cancer antibodies directly from their point of origin. In the activated lymph nodes antibody secreting cells (ASCs) are generated… >>Read More
CancerProbe Pty Ltd is an Australian Biotechnology company that has developed a unique, platform technology for identifying immune biomarkers and tumor antigens in various types of solid cancers. Based on its proprietary… >>Read More
The CancerProbe technology is a discovery tool for:
Proof of principle